Bioavailability of isradipine in young and old rats: effect of mode of administration.
The bioavailability of isradipine has been examined in 7- and 52-week-old rats after oral (12.5 mg kg-1) or intravenous (2.5 mg kg-1) doses as a solution and administration of various doses (1.8-85.5 mg kg-1) in the diet. Serial plasma samples were obtained from each rat and the drug concentration was determined by radioimmunoassay. Absorption from the dose given by gavage was rapid but when administered in a drug diet mixture, isradipine appeared in the plasma slowly and in a manner reflecting the feeding pattern. Its absolute bioavailability from the drug-diet mixture averaged 3% over the dose range tested. By gavage its bioavailability was enhanced to 5% of dose with peak plasma values approximately 7 times higher than from a comparable dose in the diet. The low oral bioavailability of isradipine in the rat was most likely due to extensive first-pass metabolism. The decline in plasma concentrations was biexponential, with a mean terminal half-life of 3.6-3.7 h after oral or intravenous dosing. The pharmacokinetic characteristics of isradipine examined were independent of the age of the rat, except that its volume of distribution decreased with age. The older rats also showed a greater inter-animal variability in isradipine bioavailability from the drug-diet mixture.
Tse
F L
FL
Department of Drug Metabolism, Sandoz Research Institute, East Hanover, New Jersey 07936.
Jaffe
J M
JM
Hassell
A E
AE
Schran
H F
HF
D000375:Aging / Q000378:metabolism; D000818:Animals; D001682:Biological Availability; D004032:Diet; D007275:Injections, Intravenous; D017275:Isradipine; D007700:Kinetics; D008297:Male; D011725:Pyridines / Q000008:administration & dosage / Q000493:pharmacokinetics*; D011863:Radioimmunoassay; D051381:Rats; D011919:Rats, Inbred Strains
D011725:Pyridines; D017275:Isradipine